Trinucleotide repeat disorders.

The discovery that expansion of unstable repeats can cause a variety of neurological disorders has changed the landscape of disease-oriented research for several forms of mental retardation, Huntington disease, inherited ataxias, and muscular dystrophy. The dynamic nature of these mutations provided an explanation for the variable phenotype expressivity within a family. Beyond diagnosis and genetic counseling, the benefits from studying these disorders have been noted in both neurobiology and cell biology. Examples include insight about the role of translational control in synaptic plasticity, the role of RNA processing in the integrity of muscle and neuronal function, the importance of Fe-S-containing enzymes for cellular energy, and the dramatic effects of altering protein conformations on neuronal function and survival. It is exciting that within a span of 15 years, pathogenesis studies of this class of disorders are beginning to reveal pathways that are potential therapeutic targets.

[1]  R. Nussbaum,et al.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein , 1993, Cell.

[2]  C. Ross,et al.  A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease–like 2 , 2001, Nature Genetics.

[3]  A. Hilliker,et al.  RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila. , 2005, Human molecular genetics.

[4]  D. Pietrobon,et al.  Calcium channels and channelopathies of the central nervous system , 2002, Molecular Neurobiology.

[5]  D. Richardson,et al.  Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron. , 2001, Biochimica et biophysica acta.

[6]  M. Koenig,et al.  Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Porteous,et al.  Dentatorubral and pallidoluysian atrophy (DRPLA) Clinical and neuropathological findings in genetically confirmed north american and european pedigrees , 1997, Movement disorders : official journal of the Movement Disorder Society.

[8]  C. Amemiya,et al.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. , 1992, Science.

[9]  A. Munnich,et al.  Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia , 2002, Heart.

[10]  R. Kopito,et al.  Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.

[11]  Janghoo Lim,et al.  ATAXIN-1 Interacts with the Repressor Capicua in Its Native Complex to Cause SCA1 Neuropathology , 2006, Cell.

[12]  S. Warren,et al.  Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. , 2001, Human molecular genetics.

[13]  Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1 , 2003, Development.

[14]  T. Cooper,et al.  Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. , 2005, Human molecular genetics.

[15]  H. Zoghbi,et al.  Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1 , 2003, Cell.

[16]  R. Carraway,et al.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.

[17]  Takanori Yamagata,et al.  Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10 , 2000, Nature Genetics.

[18]  S. Ceman,et al.  Isolation of an FMRP-Associated Messenger Ribonucleoprotein Particle and Identification of Nucleolin and the Fragile X-Related Proteins as Components of the Complex , 1999, Molecular and Cellular Biology.

[19]  M. Beal,et al.  Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease* , 2005, Journal of Biological Chemistry.

[20]  Robin A. J. Smith,et al.  Mitochondria‐targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  C. Gellera,et al.  The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. , 1999, Human molecular genetics.

[22]  R. Llinás,et al.  Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Vallee,et al.  Fast transport and retrograde movement of huntingtin and HAP 1 in axons , 1997, Neuroreport.

[24]  Peer Bork,et al.  HEAT repeats in the Huntington's disease protein , 1995, Nature Genetics.

[25]  I. Meinertzhagen,et al.  Axonal Transport of Mitochondria to Synapses Depends on Milton, a Novel Drosophila Protein , 2002, Neuron.

[26]  A. Riggs,et al.  HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence , 2005, Nucleic acids research.

[27]  S. Hersch,et al.  Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice , 2003, Journal of neurochemistry.

[28]  G. Wang,et al.  Cytoplasmic and Nuclear Retained DMPK mRNAs Are Targets for RNA Interference in Myotonic Dystrophy Cells* , 2005, Journal of Biological Chemistry.

[29]  D. Housman,et al.  Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Fisch,et al.  Coronary disease, cardioneuropathy, and conduction system abnormalities in the cardiomyopathy of Friedreich's ataxia. , 1987, British heart journal.

[31]  Giuseppe Nicastro,et al.  The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Paylor,et al.  Fmr1 knockout mice are impaired in a leverpress escape/avoidance task , 2006, Genes, brain, and behavior.

[33]  James M. Olson,et al.  Therapeutic opportunities in polyglutamine disease , 2001, Nature Medicine.

[34]  B. Van Houten,et al.  Reduction in frataxin causes progressive accumulation of mitochondrial damage. , 2003, Human molecular genetics.

[35]  F. Foury.  Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain , 1999, FEBS letters.

[36]  M. Tranfaglia,et al.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.

[37]  H. Diener,et al.  Significance of MRI-confirmed atrophy of the cranial spinal cord in Friedreich's ataxia , 2004, European archives of psychiatry and neurological sciences.

[38]  Jonathan Gray,et al.  Rb regulates proliferation and rod photoreceptor development in the mouse retina , 2004, Nature Genetics.

[39]  W. Brown,et al.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. , 2003, American journal of human genetics.

[40]  B. Byrne,et al.  Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy , 2000, The EMBO journal.

[41]  I. Weiler,et al.  Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. , 2002, American journal of medical genetics.

[42]  C. Ross,et al.  SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia , 2001, Brain Research Bulletin.

[43]  Harry T Orr,et al.  Recovery from Polyglutamine-Induced Neurodegeneration in Conditional SCA1 Transgenic Mice , 2004, The Journal of Neuroscience.

[44]  Dimitri Krainc,et al.  Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration , 2006, Cell.

[45]  Denise S Walker,et al.  Subunit interaction sites in voltage-dependent Ca2+ channels: role in channel function , 1998, Trends in Neurosciences.

[46]  I. Scheffer,et al.  Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy , 2002, Nature Genetics.

[47]  A. Joyner,et al.  Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.

[48]  T. Cooper,et al.  Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.

[49]  Stefan M Pulst,et al.  Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. , 2003, Human molecular genetics.

[50]  A. Kuwano,et al.  Dentatorubral-pallidoluysian atrophy (DRPLA): clinical, genetic, and neuroradiologic studies in a family , 1995, Journal of the Neurological Sciences.

[51]  Blair R. Leavitt,et al.  Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.

[52]  L. Pallanck,et al.  A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. , 2002, Genetics.

[53]  R. Nussbaum,et al.  The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. , 1995, The EMBO journal.

[54]  James R. Burke,et al.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.

[55]  L. Balcer,et al.  Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy. , 2002, Archives of neurology.

[56]  Làszlò Tora,et al.  Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. , 2004, Human molecular genetics.

[57]  J. Gécz,et al.  Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. , 1997, Genomics.

[58]  P. Jin,et al.  New insights into fragile X syndrome: from molecules to neurobehaviors. , 2003, Trends in biochemical sciences.

[59]  D. Chakravarti,et al.  Ataxin-3 Is a Histone-binding Protein with Two Independent Transcriptional Corepressor Activities* , 2002, The Journal of Biological Chemistry.

[60]  C. Harrison,et al.  The fragile X: a scanning electron microscope study. , 1983, Journal of medical genetics.

[61]  T. Ashizawa,et al.  The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10 , 2006, Neurology.

[62]  R. Albin,et al.  Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues , 1993, Nature Genetics.

[63]  D. Housman,et al.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.

[64]  H. Paulson,et al.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 , 1999, Nature Genetics.

[65]  M. Swanson,et al.  Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. , 1996, Nucleic acids research.

[66]  C. Ware,et al.  Polyglutamine-Expanded Ataxin-7 Antagonizes CRX Function and Induces Cone-Rod Dystrophy in a Mouse Model of SCA7 , 2001, Neuron.

[67]  Tim-Rasmus Kiehl,et al.  Generation and characterization of Sca2 (ataxin-2) knockout mice. , 2006, Biochemical and biophysical research communications.

[68]  H. Orr,et al.  Beyond the Qs in the polyglutamine diseases. , 2001, Genes & development.

[69]  Ruth Luthi-Carter,et al.  Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice , 2003, The Journal of Neuroscience.

[70]  R. E. Hughes.  Polyglutamine Disease: Acetyltransferases Awry , 2002, Current Biology.

[71]  D. Housman,et al.  Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[72]  B. Chait,et al.  Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[73]  G. K. Henry,et al.  INFORMATION PROCESSING SPEED OF CHILDREN WITH FRIEDREICH'S ATAXIA , 1986, Developmental medicine and child neurology.

[74]  H. Lehrach,et al.  A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. , 2004, Molecular cell.

[75]  William B. Dobyns,et al.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel , 1997, Nature Genetics.

[76]  J. Santamaria,et al.  A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure , 1983, Journal of the Neurological Sciences.

[77]  C. B. Smith,et al.  Postadolescent Changes in Regional Cerebral Protein Synthesis: An In Vivo Study in the Fmr1 Null Mouse , 2005, The Journal of Neuroscience.

[78]  Huiyi Wang,et al.  Castration Restores Function and Neurofilament Alterations of Aged Symptomatic Males in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy , 2004, The Journal of Neuroscience.

[79]  J. Rossi,et al.  Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[80]  Changming Sun,et al.  Spinocerebellar ataxia type 2 presenting as familial levodopa‐responsive parkinsonism , 2001, Annals of neurology.

[81]  S. Newfeld,et al.  A screen for modifiers of decapentaplegic mutant phenotypes identifies lilliputian, the only member of the Fragile-X/Burkitt's Lymphoma family of transcription factors in Drosophila melanogaster. , 2001, Genetics.

[82]  J. Yates,et al.  Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[83]  Barrington G. Burnett,et al.  The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. , 2003, Human molecular genetics.

[84]  S. Perlman,et al.  Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia , 2006, Nature chemical biology.

[85]  S. Hirai,et al.  Ataxin-3 Is Translocated into the Nucleus for the Formation of Intranuclear Inclusions in Normal and Machado–Joseph Disease Brains , 2000, Experimental Neurology.

[86]  Scott T. Brady,et al.  Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport , 2003, Neuron.

[87]  S. Floresco,et al.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.

[88]  L. Ranum,et al.  Pathogenic RNA repeats: an expanding role in genetic disease. , 2004, Trends in genetics : TIG.

[89]  B. D. de Vries,et al.  The fragile X syndrome. , 1998, Journal of medical genetics.

[90]  J. Bell,et al.  A PEDIGREE OF MENTAL DEFECT SHOWING SEX-LINKAGE , 1943, Journal of neurology and psychiatry.

[91]  Robert Tjian,et al.  Eukaryotic coactivators associated with the TATA box binding protein , 1992 .

[92]  K. M. Huber,et al.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. , 2006, Journal of neurophysiology.

[93]  M. MacDonald,et al.  HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. , 2005, Human molecular genetics.

[94]  Heather A. O'Neill,et al.  Yeast Frataxin Sequentially Chaperones and Stores Iron by Coupling Protein Assembly with Iron Oxidation* , 2003, Journal of Biological Chemistry.

[95]  H. Zoghbi,et al.  Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. , 2001, Human molecular genetics.

[96]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[97]  H. Lubs.  A marker X chromosome. , 1969, American journal of human genetics.

[98]  S Kobayashi,et al.  A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? , 1999, Human molecular genetics.

[99]  Jiandie D. Lin,et al.  Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice , 2004, Cell.

[100]  W. Brown,et al.  Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. , 1999, American journal of medical genetics.

[101]  S. Zeitlin,et al.  Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro. , 2006, Human molecular genetics.

[102]  I. G. Fantus,et al.  Glucose intolerance in first-degree relatives of patients with Friedreich's ataxia is associated with insulin resistance: evidence for a closely linked inherited trait. , 1991, Metabolism: clinical and experimental.

[103]  Christopher A Ross,et al.  Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.

[104]  H. Zoghbi,et al.  Impaired Conditioned Fear and Enhanced Long-Term Potentiation inFmr2 Knock-Out Mice , 2002, The Journal of Neuroscience.

[105]  W. Brown,et al.  Fmr1 knockout mouse has a distinctive strain-specific learning impairment , 2000, Neuroscience.

[106]  J. Melki,et al.  Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits , 2001, Nature Genetics.

[107]  Leslie M Thompson,et al.  Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[108]  Sanne de Wit,et al.  Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse , 2002, Hippocampus.

[109]  Fumiaki Tanaka,et al.  Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. , 2004, Human molecular genetics.

[110]  M. MacDonald,et al.  Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. , 2002, Human molecular genetics.

[111]  T. Cooper,et al.  RNA-mediated neuromuscular disorders. , 2006, Annual review of neuroscience.

[112]  J. Rommens,et al.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy , 1998, Nature Genetics.

[113]  H. Zoghbi,et al.  A Long CAG Repeat in the Mouse Sca1 Locus Replicates SCA1 Features and Reveals the Impact of Protein Solubility on Selective Neurodegeneration , 2002, Neuron.

[114]  A. Young.  Huntingtin in health and disease. , 2003, The Journal of clinical investigation.

[115]  S. Warren,et al.  Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells , 1999, Nature Genetics.

[116]  Harry T Orr,et al.  RNA association and nucleocytoplasmic shuttling by ataxin-1 , 2005, Journal of Cell Science.

[117]  F. Westermann,et al.  Ataxin-2 promotes apoptosis of human neuroblastoma cells , 2003, Oncogene.

[118]  A. Munnich,et al.  Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. , 2001, Human molecular genetics.

[119]  M. Hayden,et al.  Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity* , 2003, The Journal of Biological Chemistry.

[120]  P. Worley,et al.  Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. , 1997, Human molecular genetics.

[121]  Richard Paylor,et al.  Dynamic Translational and Proteasomal Regulation of Fragile X Mental Retardation Protein Controls mGluR-Dependent Long-Term Depression , 2006, Neuron.

[122]  G. Campanella,et al.  Otoneurological findings in Friedreich's ataxia and other inherited neuropathies. , 1986, Audiology : official organ of the International Society of Audiology.

[123]  A. Paetau,et al.  Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2 , 2003, Neurology.

[124]  Juan Botas,et al.  The AXH Domain of Ataxin-1 Mediates Neurodegeneration through Its Interaction with Gfi-1/Senseless Proteins , 2005, Cell.

[125]  Richard G. Brusch,et al.  Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.

[126]  Hung-Ying Kao,et al.  Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[127]  R Greim,et al.  Exon/intron structure of the human AF‐4 gene, a member of the AF‐4/LAF‐4/FMR‐2 gene family coding for a nuclear protein with structural alterations in acute leukaemia , 1997, British journal of haematology.

[128]  O. Onodera,et al.  Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.

[129]  Thomas Lengauer,et al.  An integrative approach to gain insights into the cellular function of human ataxin-2. , 2005, Journal of molecular biology.

[130]  Harry T Orr,et al.  Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.

[131]  N. Funata,et al.  Recruitment of Nonexpanded Polyglutamine Proteins to Intranuclear Aggregates in Neuronal Intranuclear Hyaline Inclusion Disease , 2001, Journal of neuropathology and experimental neurology.

[132]  He Li,et al.  Interaction of Huntington Disease Protein with Transcriptional Activator Sp1 , 2002, Molecular and Cellular Biology.

[133]  K. Hofmann,et al.  Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. , 2003, Human molecular genetics.

[134]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[135]  K. Fischbeck,et al.  Therapeutics development for triplet repeat expansion diseases , 2005, Nature Reviews Genetics.

[136]  Peter K. Todd,et al.  The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[137]  Kiyoshi Iwabuchi,et al.  Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias – triple-labeling immunofluorescence study , 2001, Acta Neuropathologica.

[138]  T. Bird,et al.  An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) , 1999, Nature Genetics.

[139]  D. Nelson,et al.  Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. , 2006, Human molecular genetics.

[140]  A T Hoogeveen,et al.  FMRP is associated to the ribosomes via RNA. , 1996, Human molecular genetics.

[141]  M. Lentze,et al.  A novel stable polyalanine [poly(A)] expansion in the HOXA13 gene associated with hand-foot-genital syndrome: proper function of poly(A)-harbouring transcription factors depends on a critical repeat length? , 2002, Human Genetics.

[142]  Y. Agid,et al.  Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion , 1997, Nature Genetics.

[143]  A. Smith,et al.  Müller-cell-derived leukaemia inhibitory factor arrests rod photoreceptor differentiation at a postmitotic pre-rod stage of development. , 1997, Development.

[144]  C. Sewry,et al.  Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts , 2006, Human Genetics.

[145]  E. De Schutter,et al.  Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome , 2005, Neuron.

[146]  J Grigsby,et al.  Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). , 2006, Brain : a journal of neurology.

[147]  S. Batalov,et al.  Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[148]  Effat S. Emamian,et al.  Serine 776 of Ataxin-1 Is Critical for Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 2003, Neuron.

[149]  S. Cannon,et al.  Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. , 2002, Molecular cell.

[150]  K. Fischbeck,et al.  Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. , 2000, Human molecular genetics.

[151]  T. Cooper,et al.  Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy , 2005, Journal of Cell Science.

[152]  M. D. Del Bigio,et al.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. , 2002, Brain : a journal of neurology.

[153]  Tian Xu,et al.  Drosophila Atrophin Homolog Functions as a Transcriptional Corepressor in Multiple Developmental Processes , 2002, Cell.

[154]  R. Gibbs,et al.  Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island , 1996, Nature Genetics.

[155]  P Trouillas,et al.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. , 1997, Human molecular genetics.

[156]  M. Pandolfo,et al.  Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.

[157]  I. Weiler,et al.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. , 2001, American journal of medical genetics.

[158]  J. Nemes,et al.  The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1). , 2000, Human molecular genetics.

[159]  A. Munnich,et al.  Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study , 1999, The Lancet.

[160]  L. Pallanck,et al.  Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. , 2006, Human molecular genetics.

[161]  Heather A. O'Neill,et al.  Frataxin Acts as an Iron Chaperone Protein to Modulate Mitochondrial Aconitase Activity , 2004, Science.

[162]  E. Wilson,et al.  The androgen receptor: an overview. , 1994, Recent progress in hormone research.

[163]  S. Naylor,et al.  Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.

[164]  P. Hagerman,et al.  Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1 , 2007, The Lancet Neurology.

[165]  Michael Courtois,et al.  PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis , 2005, PLoS Biology.

[166]  É. Khandjian,et al.  Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome , 2004, Journal of Medical Genetics.

[167]  I. Kanazawa,et al.  SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. , 2001, Human molecular genetics.

[168]  R. Tjian,et al.  In Vitro Analysis of Huntingtin-Mediated Transcriptional Repression Reveals Multiple Transcription Factor Targets , 2005, Cell.

[169]  H. Zoghbi,et al.  Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. , 2004, Human molecular genetics.

[170]  R. Jensen,et al.  Suppression of a defect in mitochondrial protein import identifies cytosolic proteins required for viability of yeast cells lacking mitochondrial DNA. , 2003, Genetics.

[171]  J. Gusella,et al.  The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor , 2002, BMC Neuroscience.

[172]  M. MacDonald,et al.  Huntingtin: Alive and Well and Working in Middle Management , 2003, Science's STKE.

[173]  H. Paulson,et al.  Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. , 2005, Molecular cell.

[174]  A. Jacobson,et al.  Pbp1p, a Factor Interacting withSaccharomyces cerevisiae Poly(A)-Binding Protein, Regulates Polyadenylation , 1998, Molecular and Cellular Biology.

[175]  A. Spada,et al.  Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport , 2006, Nature Neuroscience.

[176]  J S Child,et al.  Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients. , 1986, Journal of the American College of Cardiology.

[177]  A. Munnich,et al.  Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.

[178]  W. Hauswirth,et al.  A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.

[179]  Peng Jin,et al.  RNA-Mediated Neurodegeneration Caused by the Fragile X Premutation rCGG Repeats in Drosophila , 2003, Neuron.

[180]  S. Pulst,et al.  Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human , 2000, Nature Genetics.

[181]  Virginia E. Papaioannou,et al.  Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue , 1995, Nature Genetics.

[182]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[183]  M. Koenig,et al.  Friedreich ataxia: the oxidative stress paradox. , 2005, Human molecular genetics.

[184]  A Dürr,et al.  Clinical and genetic abnormalities in patients with Friedreich's ataxia. , 1996, The New England journal of medicine.

[185]  H. Zoghbi,et al.  The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. , 2001, Human molecular genetics.

[186]  G. Sobue,et al.  Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy , 2003, Nature Medicine.

[187]  Huda Y. Zoghbi,et al.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.

[188]  M. Ristow,et al.  The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. , 2002, Human molecular genetics.

[189]  T. Cooper,et al.  Pre-mRNA splicing and human disease. , 2003, Genes & development.

[190]  B. Oostra,et al.  Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. , 2000, Experimental cell research.

[191]  Pier Paolo Di Fiore,et al.  Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[192]  Guy Nagels,et al.  Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.

[193]  C. Ross,et al.  Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.

[194]  H. Zoghbi,et al.  Identification of genes that modify ataxin-1-induced neurodegeneration , 2000, Nature.

[195]  S. Luquet,et al.  Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. , 2006, Cell metabolism.

[196]  G. Kozlov,et al.  Structure and function of the C-terminal PABC domain of human poly(A)-binding protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[197]  A. Berns,et al.  Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice , 1996, Nature Genetics.

[198]  R. D'Hooge,et al.  Mildly impaired water maze performance in maleFmr1 knockout mice , 1997, Neuroscience.

[199]  L. Thompson,et al.  Targeting aggregation in the development of therapeutics for the treatment of Huntington’s disease and other polyglutamine repeat diseases , 2003, Expert opinion on therapeutic targets.

[200]  R. J. White,et al.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.

[201]  R. Griggs,et al.  Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. , 1978, The Journal of clinical investigation.

[202]  P G Bhide,et al.  Expression of Normal and Mutant Huntingtin in the Developing Brain , 1996, The Journal of Neuroscience.

[203]  C. Gomez,et al.  C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity. , 2006, Human molecular genetics.

[204]  C A Ross,et al.  Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity , 2001, Science.

[205]  M. Muratani,et al.  How the ubiquitin–proteasome system controls transcription , 2003, Nature Reviews Molecular Cell Biology.

[206]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[207]  D. Hilton‐Jones,et al.  Clinical and molecular aspects of the myotonic dystrophies: A review , 2005, Muscle & nerve.

[208]  B. Birren,et al.  Disruption of the nuclear hormone receptor RORα in staggerer mice , 1996, Nature.

[209]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[210]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[211]  G. Sutherland.  Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. , 1977, Science.

[212]  T. Webb,et al.  Prevalence of fragile X syndrome. , 1996, Journal of medical genetics.

[213]  L. Raymond,et al.  Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin , 2006, Cell.

[214]  M. Swanson,et al.  Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. , 2001, Human molecular genetics.

[215]  C. Ehresmann,et al.  The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif , 2001, The EMBO journal.

[216]  S. T. Warren,et al.  Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function , 1999, Neuroscience.

[217]  M. Mutsuddi,et al.  The Spinocerebellar Ataxia 8 Noncoding RNA Causes Neurodegeneration and Associates with Staufen in Drosophila , 2004, Current Biology.

[218]  D. Nelson,et al.  (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. , 2000, Human molecular genetics.

[219]  B. W. Richards,et al.  Fragile X-linked mental retardation: the Martin-Bell syndrome. , 2008, Journal of mental deficiency research.

[220]  T. Cooper,et al.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy , 2001, Nature Genetics.

[221]  T. Godfrey,et al.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. , 2000, American journal of human genetics.

[222]  S. Hersch,et al.  Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[223]  J. Darnell,et al.  Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.

[224]  J. Olson,et al.  Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. , 2002, Human molecular genetics.

[225]  D. Housman,et al.  Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy , 1996, Nature Genetics.

[226]  I. Weiler,et al.  Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[227]  B. Schmidt,et al.  Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. , 2002, Neurology.

[228]  A. Delacourte,et al.  Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. , 2001, Human molecular genetics.

[229]  Fabrice P Cordelières,et al.  Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.

[230]  G. Guillén,et al.  Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter cause specific Purkinje cell degeneration in transgenic mice , 2006, Neuroscience Letters.

[231]  Daniela C. Zarnescu,et al.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway , 2004, Nature Neuroscience.

[232]  S. Narumiya,et al.  Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo , 1996, Nature Genetics.

[233]  René Hen,et al.  Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.

[234]  M. Hayden,et al.  Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[235]  K. Fischbeck,et al.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.

[236]  H. Zoghbi,et al.  Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. , 2005, Human molecular genetics.

[237]  Georg Auburger,et al.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2 , 1996, Nature Genetics.

[238]  M. Meyer,et al.  Molecular and clinical findings in a family with dentatorubral‐pallidoluysian atrophy , 1995, Annals of neurology.

[239]  M. Sanders,et al.  Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families. , 1994, Brain : a journal of neurology.

[240]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[241]  H. Zoghbi,et al.  RORα-Mediated Purkinje Cell Development Determines Disease Severity in Adult SCA1 Mice , 2006, Cell.

[242]  G Campanella,et al.  The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. , 1996, American journal of human genetics.

[243]  Yan Wang,et al.  Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.

[244]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[245]  T. Schulz,et al.  Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. , 2005, Human molecular genetics.

[246]  C. E. Pearson,et al.  Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells , 2002, Nature Genetics.

[247]  M. Koenig,et al.  Friedreich ataxia: a paradigm for mitochondrial diseases. , 2002, Current opinion in genetics & development.

[248]  C. Ware,et al.  Polyglutamine-Expanded Ataxin-7 Promotes Non-Cell-Autonomous Purkinje Cell Degeneration and Displays Proteolytic Cleavage in Ataxic Transgenic Mice , 2002, The Journal of Neuroscience.

[249]  F. Porteu,et al.  Cloning and Characterization of a Family of Proteins Associated with Mpl* , 2002, The Journal of Biological Chemistry.

[250]  H. Zoghbi,et al.  Mouse and fly models of neurodegeneration. , 2002, Trends in genetics : TIG.

[251]  B. Oostra,et al.  In vitro reactivation of the FMR1 gene involved in fragile X syndrome. , 1998, Human molecular genetics.

[252]  W. Alaynick,et al.  Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin‐1 , 2005, The EMBO journal.

[253]  D. Absher,et al.  FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. , 1997, Molecular cell.

[254]  S. Eddy,et al.  Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. , 2005, Genes & development.

[255]  T. Cooper,et al.  Dynamic balance between activation and repression regulates pre‐mRNA alternative splicing during heart development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[256]  T. Cooper,et al.  Insulin receptor splicing alteration in myotonic dystrophy type 2. , 2004, American journal of human genetics.

[257]  T. Ebner,et al.  Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8 , 2006, Nature Genetics.

[258]  S. Tapscott,et al.  Myotonic dystrophy: emerging mechanisms for DM1 and DM2. , 2007, Biochimica et biophysica acta.

[259]  Dimitri Krainc,et al.  Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease , 2002, Science.

[260]  Shigenobu Nakamura,et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.

[261]  S. Hersch,et al.  Interaction of Huntingtin-Associated Protein with Dynactin P150Glued , 1998, The Journal of Neuroscience.

[262]  S. Pulst,et al.  Expression of ataxin‐2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2 , 1999, Annals of neurology.

[263]  F. Foury,et al.  Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria , 1997, FEBS letters.

[264]  Andrea Crotti,et al.  Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes , 2003, Nature Genetics.

[265]  T. Tabata,et al.  Androgen-Dependent Neurodegeneration by Polyglutamine-Expanded Human Androgen Receptor in Drosophila , 2002, Neuron.

[266]  R. Kopito,et al.  Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.

[267]  Kendal Broadie,et al.  The Drosophila Fragile X Gene Negatively Regulates Neuronal Elaboration and Synaptic Differentiation , 2004, Current Biology.

[268]  Rodney C. Samaco,et al.  Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes , 2007, Nature Genetics.

[269]  J. Cowan,et al.  Iron-sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. , 2003, Journal of the American Chemical Society.

[270]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[271]  S. Warren,et al.  The fragile X mental retardation protein inhibits translation via interacting with mRNA. , 2001, Nucleic acids research.

[272]  Harry T Orr,et al.  Targeted Deletion of a Single Sca8 Ataxia Locus Allele in Mice Causes Abnormal Gait, Progressive Loss of Motor Coordination, and Purkinje Cell Dendritic Deficits , 2006, The Journal of Neuroscience.

[273]  Olaf Riess,et al.  Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17) , 2003, Annals of neurology.

[274]  R I Richards,et al.  Dynamic mutations: a decade of unstable expanded repeats in human genetic disease. , 2001, Human molecular genetics.

[275]  S. Folstein,et al.  Huntington's disease gene (IT15) is widely expressed in human and rat tissues , 1993, Neuron.

[276]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[277]  Melvin G McInnis,et al.  Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12 , 1999, Nature Genetics.

[278]  P. Harper,et al.  Genetic risks for children of women with myotonic dystrophy. , 1991, American journal of human genetics.

[279]  H. Zoghbi,et al.  Expression analysis of the ataxin–1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals , 1995, Nature Genetics.

[280]  M. Mahadevan,et al.  Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy , 2006, Nature Genetics.

[281]  P. Hagerman,et al.  Protein composition of the intranuclear inclusions of FXTAS. , 2006, Brain : a journal of neurology.

[282]  P. Hagerman,et al.  The fragile-X premutation: a maturing perspective. , 2004, American journal of human genetics.

[283]  T. Cooper,et al.  MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1. , 2006, Human molecular genetics.

[284]  S. Puglisi‐Allegra,et al.  Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex , 2004, Behavioural pharmacology.

[285]  Michael S. Levine,et al.  Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice , 2000, Nature Genetics.

[286]  A. Dancis,et al.  Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1). , 2003, Human molecular genetics.

[287]  G. Sobue,et al.  Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy , 2002, Neuron.

[288]  Edwin J. Weeber,et al.  SCA7 Knockin Mice Model Human SCA7 and Reveal Gradual Accumulation of Mutant Ataxin-7 in Neurons and Abnormalities in Short-Term Plasticity , 2003, Neuron.

[289]  T. Cooper,et al.  Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. , 2002, Molecular cell.

[290]  D. Crawford,et al.  Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. , 2002, American journal of human genetics.

[291]  Erich E Wanker,et al.  The hunt for huntingtin function: interaction partners tell many different stories. , 2003, Trends in biochemical sciences.

[292]  H. Zoghbi,et al.  Glutamine-Expanded Ataxin-7 Alters TFTC/STAGA Recruitment and Chromatin Structure Leading to Photoreceptor Dysfunction , 2006, PLoS biology.

[293]  T. Ashizawa,et al.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy. , 1992, Science.

[294]  E. Hafen,et al.  Lilliputian: an AF4/FMR2-related protein that controls cell identity and cell growth. , 2001, Development.

[295]  C. Duyckaerts,et al.  Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions , 2004, Acta Neuropathologica.

[296]  H. Paulson,et al.  Poly-ubiquitin Binding by the Polyglutamine Disease Protein Ataxin-3 Links Its Normal Function to Protein Surveillance Pathways* , 2004, Journal of Biological Chemistry.

[297]  H. Zoghbi,et al.  SUMOylation of the Polyglutamine Repeat Protein, Ataxin-1, Is Dependent on a Functional Nuclear Localization Signal* , 2005, Journal of Biological Chemistry.

[298]  Huda Y. Zoghbi,et al.  Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles , 2005, Nature Reviews Genetics.

[299]  I. Kanazawa,et al.  Interaction between Mutant Ataxin-1 and PQBP-1 Affects Transcription and Cell Death , 2002, Neuron.

[300]  J. Skinner,et al.  Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain , 2000, The European journal of neuroscience.

[301]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[302]  T. Klockgether,et al.  SCA6 is caused by moderate CAG expansion in the alpha1A-voltage-dependent calcium channel gene. , 1997, Human molecular genetics.

[303]  S. di Donato,et al.  Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial , 2003, Neurology.

[304]  S. Pulst,et al.  A novel protein with RNA-binding motifs interacts with ataxin-2. , 2000, Human molecular genetics.

[305]  J. Nemes,et al.  Erratum: The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1) (Human Molecular Genetics (2000) vol. 9 (1543-1551)) , 2000 .

[306]  G. Pigino,et al.  JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport , 2006, Nature Neuroscience.

[307]  J. Opitz,et al.  Consideration of connective tissue dysfunction in the fragile X syndrome. , 1984, American journal of medical genetics.

[308]  G. Sobue,et al.  X-linked recessive bulbospinal neuronopathy. A clinicopathological study. , 1989, Brain : a journal of neurology.

[309]  G. Sutherland,et al.  Idebenone treatment in Friedreich’s ataxia , 2003, Neurology.

[310]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[311]  K. Davies,et al.  Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation , 1993, Cell.

[312]  R. Wilson,et al.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X , 2001, Neurology.

[313]  A. Dejean,et al.  Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.

[314]  Brigitte Bogert,et al.  The fragile X-related Gene Affects the Crawling Behavior of Drosophila Larvae by Regulating the mRNA Level of the DEG/ENaC Protein Pickpocket1 , 2004, Current Biology.

[315]  John I. Clark,et al.  Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy , 2000, Nature Genetics.

[316]  H. Lehrach,et al.  Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. , 1998, Human molecular genetics.

[317]  C. Pablos,et al.  Brain-stem auditory evoked potentials and blink reflex in friedreich's ataxia , 1991, Journal of Neurology.

[318]  K. Fischbeck,et al.  Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention? , 2002, Trends in molecular medicine.

[319]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[320]  J. Gécz,et al.  Identification of the gene FMR2, associated with FRAXE mental retardation , 1996, Nature Genetics.

[321]  D. Loesch,et al.  FRAXE and mental retardation. , 1995, Journal of medical genetics.

[322]  J. Sarsero,et al.  Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia , 2003, The journal of gene medicine.

[323]  Mariette Schrier,et al.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. , 2003, Human molecular genetics.

[324]  P. Friedreich,et al.  Ueber degenerative Atrophie der spinalen Hinterstränge , 2005, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[325]  A. Ostareck-Lederer,et al.  Evidence that fragile X mental retardation protein is a negative regulator of translation. , 2001, Human molecular genetics.

[326]  E. Monrós,et al.  Friedreich's ataxia: idebenone treatment in early stage patients. , 2002, Neuropediatrics.

[327]  Harry T Orr,et al.  Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice , 1999, Neuron.